Global Access
There is a vast, underserved segment of the market looking for unique, direct investment opportunities, high-quality, off-market deals, and solutions to complex challenges.
Supernova Invest
Supernova Invest is a European multi-stage VC firm with currently €850m AUM. Our team provides unparalleled expertise and patient capital in the fields of Digital, Industrial Technologies, Healthcare and Cleantech […]
Karista
Karista is an early-growth investment firm backing ambitious entrepreneurs across Europe. For nearly 25 years, we have supported over 100 startups and scale-ups, many of which have achieved successful exits […]
Hadean Ventures
Hadean Ventures is a European life science VC fund manager with c. EUR 230m assets under management. We invest across all healthcare verticals and stages, in products with the potential […]
Arch Venture Partners
Over 30 years, ARCH has backed disruptive science companies with as little as $50K to as much as hundreds of millions of dollars, per company. We are not interested in […]
Wellington Partners
Since 1998, Wellington Partners has been helping outstanding entrepreneurs to turn their ideas into a reality and to become global leaders in their field of business. As a venture capital […]
Plug and Play
We are dedicated to driving innovation within large organizations, helping them stay ahead of the curve and thrive in today’s rapidly evolving business landscape. By selecting strategically-aligned startups that meet […]
HERAN Partners
HERAN PARTNERS is a European investment fund founded in 2020 with a specific focus on Enabling Technologies in Life Sciences and Healthcare. With a clear focus on European HealthTech & […]
Borski Fund
Picture this: 5% of all Venture Capital investment go to diverse teams made up of both males and females. Only 1% is invested in all-female teams. This leaves 94%(!) of […]
MDC Associates, Inc.
For over three decades, MDC has been the Clinical Research Organization (CRO) partner of choice for diagnostic innovators, guiding companies through the regulatory and clinical hurdles to bring critical tests […]
